# A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection

> **NCT00820053** · PHASE2 · COMPLETED · sponsor: **Eastern Hepatobiliary Surgery Hospital** · enrollment: 450 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** epirubicin and lipiodol

## Key facts

- **NCT ID:** NCT00820053
- **Lead sponsor:** Eastern Hepatobiliary Surgery Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820053, "A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00820053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*